Mdmx promotes genomic instability independent of p53 and Mdm2

por Carrillo, Alexia M., Bouska, Alyssa, Arrate, Maria Pia, Eischen, Christine M.
Publicado 2014

Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model

por Ramsey, Haley E., Oganesian, Aram, Gorska, Agnieszka E., Fuller, Londa, Arrate, Maria, Boyd, Kelli, Keer, Harold, Azab, Mohammad, Savona, Michael R.
Publicado 2020

A deficiency in Mdm2 binding protein (MTBP) inhibits Myc-induced B cell proliferation and lymphomagenesis

por Odvody, Jessica, Vincent, Tiffaney, Arrate, Maria Pia, Grieb, Brian, Wang, Shuo, Garriga, Judit, Lozano, Guillermina, Iwakuma, Tomoo, Haines, Dale S., Eischen, Christine M.
Publicado 2010

Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution

por Puccetti, Matthew V., Fischer, Melissa A., Arrate, Maria Pia, Boyd, Kelli L., Duszynski, Robert J., Bétous, Rémy, Cortez, David, Eischen, Christine M.
Publicado 2016

Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes

por Fischer, Melissa A., Song, Yuanbin, Arrate, Maria P., Gbyli, Rana, Villaume, Matthew T., Smith, Brianna N., Childress, Merrida A., Stricker, Thomas P., Halene, Stephanie, Savona, Michael R.
Publicado 2022

Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia

por Cojocari, Dan, Smith, Brianna N, Purkal, Julie J., Arrate, Maria P., Huska, Jason D., Xiao, Yu, Gorska, Agnieszka, Hogdal, Leah J., Ramsey, Haley E., Boghaert, Erwin R., Phillips, Darren C., Savona, Michael R.
Publicado 2021